Lilly, Boehringer revise terms of diabetes drugs alliance
October 29, 2014 at 08:55 AM EDT
Oct 29 (Reuters) - Eli Lilly and Co and German drugmaker Boehringer Ingelheim said they had revised the structure of their diabetes alliance for some countries.